Gary Hardiman

12.9k citations
169 papers · 8.9k indexed · 4 hit papers · h-index 40

Gary Hardiman

164 papers receiving 8.7k citations

Hit Papers

Human cardiac or...295199720262006201650010001.5k

Peers

Gary Hardiman
Comparison fields: 5 of 161
  • Immunology 3.2k
  • Aging 174
  • Oncology 1.9k
  • Cancer Research 971
  • Immunology and Allergy 381
Replace Yang Liao with:
Yang Liao Australia
Paul Theodor Pyl Sweden
Stefka Tyanova Germany
Alan Przybyla United States
Mark D. Fleming United States
Zheng-gang Liu United States
Alan R. Prescott United Kingdom
Yanyan Han China
Jens Andersen Denmark
Bing Su United States
Gary Hardiman relative to Yang Liao Australia Yang Liao's profile →
Citations per field
00.5×3.2×
Yang Liao · 1×
Citations per year

Countries citing papers authored by Gary Hardiman

Since Specialization
Citations

This map shows the geographic impact of Gary Hardiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Hardiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Hardiman more than expected).

Fields of papers citing papers by Gary Hardiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Hardiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Hardiman. The network helps show where Gary Hardiman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary Hardiman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Hardiman Line = papers co-authored together Gary Hardiman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20245
4 20244
5 20238
6 20236
7 20237
8 202213
9 202216
10 20215
11 202114
12 202020
13 201934
14 201877
15 20186
16 20187
17 201638
18 2010264
19 2010108
20 200838

About Gary Hardiman

Gary Hardiman is a scholar working on Aging, Physiology and Health, Toxicology and Mutagenesis, having authored 169 papers that have together received 8.9k indexed citations. Recurring topics across this work include Gene expression and cancer classification (19 papers), Reproductive biology and impacts on aquatic species (14 papers), Environmental Toxicology and Ecotoxicology (12 papers), Microplastics and Plastic Pollution (12 papers), Effects and risks of endocrine disrupting chemicals (12 papers), Spaceflight effects on biology (11 papers), Molecular Biology Techniques and Applications (10 papers) and Aquaculture Nutrition and Growth (10 papers). The work is most often cited by research in Immunology (3.2k citations), Aging (174 citations) and Oncology (1.9k citations). Gary Hardiman has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include J. Fernando Bazán, Robert A. Kastelein, Jackie C. Timans, Fernando Rock, Kevin B. Bacon, Albert Zlotnik, Dévora L. Rossi, Wei Wang, Thomas J. Schall and David R. Greaves. Their work appears in journals such as Pharmacogenomics, PLoS ONE, Genes, Scientific Reports and General and Comparative Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026